Marie-Paule Sablin

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial

Christophe Le Tourneau, Jean-Pierre Delord, Anthony Gonçalvès et al. · The Lancet Oncology · 2015 · 1.1K citations

Advanced Cancer, Drug Targeting, Oncology +12

Changes in Tumor Density in Patients with Advanced Hepatocellular Carcinoma Treated with Sunitinib

Sandrine Faivre, Magaly Zappa, Valérie Vilgrain et al. · Clinical Cancer Research · 2011 · 89 citations

Clinical study of the novel cyclin-dependent kinase inhibitor dinaciclib in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia patients

Claire Fabre, Marco Gobbi, Cyrine Ezzili et al. · Cancer Chemotherapy and Pharmacology · 2014 · 49 citations

Hematological Malignancy, Oncology, Medicine +7

Identification of new candidate therapeutic target genes in head and neck squamous cell carcinomas

Marie-Paule Sablin, Coraline Dubot, Jerzy Klijanienko et al. · Oncotarget · 2016 · 20 citations · Full text